Stimulating severe COVID-19: the potential role of GM-CSF antagonism.

Leavis, Helen L; van de Veerdonk, Frank L; Murthy, Srinivas

Leavis, Helen L; van de Veerdonk, Frank L; Murthy, Srinivas.

Leavis HL; Department of Rheumatology and Clinical Immunology, Utrecht University, University Medical Center Utrecht, Netherlands.
van de Veerdonk FL; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
Murthy S; Faculty of Medicine, University of British Columbia, Vancouver, BC V6H 3V4, Canada. Electronic address: srinivas.murthy@cw.bc.ca.

Lancet Respir Med ; 10(3): 223-224, 2022 03.

Article in English | MEDLINE | ID: covidwho-1550169

Subject(s)

COVID-19; Granulocyte-Macrophage Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Granulocyte-Macrophage Colony-Stimulating Factor / COVID-19 Limits: Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article Affiliation country: S2213-2600(21)00539-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google